Stay up-to-date with news about our innovative clinical trials, The Brain Tumor Center team members, and our latest research.

Unparalleled expertise & options

Unparalleled expertise & options

Families find life-changing treatments and care available through Siteman Kids.

Innovation by collaboration

Innovation by collaboration

The brightest minds solving brain cancer’s toughest challenges.

Researchers make glioblastoma cells visible to attacking immune cells

Researchers make glioblastoma cells visible to attacking immune cells

Strategy involves placing targets on deadly cancer’s cells, potentially making them vulnerable to immunotherapies

This is(n’t) Cancer: Advances Against Brain Tumors, Benign or Not

This is(n’t) Cancer: Advances Against Brain Tumors, Benign or Not

WashU Medicine neurosurgeon Albert Kim, MD, PhD, director of The Brain Tumor Center at Siteman, explains minimally invasive surgery techniques and other new treatments that speed recovery for benign tumor patients.

Study increases understanding of why recurrent meningiomas are aggressive

Study increases understanding of why recurrent meningiomas are aggressive

Researchers at Baylor College of Medicine and WashU Medicine have identified clinical and genetic predictors of multiply recurrent meningiomas (MRMs), a most aggressive form of this common brain tumor.

Johanns Appointed Medical Director of The Brain Tumor Center at Siteman

Johanns Appointed Medical Director of The Brain Tumor Center at Siteman

Tanner Johanns, MD, PhD, a board-certified Washington University medical oncologist, has been named medical director of The Brain Tumor Center at Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.

Patel Named Surgical Director of Pituitary Center

Patel Named Surgical Director of Pituitary Center

Neurosurgeon Bhuvic Patel, MD, has been appointed surgical director of the Pituitary Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.

The return of the Christopher Davidson Forum

The return of the Christopher Davidson Forum

On Sept. 13 and 14, more than 130 brain tumor researchers from around the country gathered at WashU for the 2024 Christopher Davidson Forum (CDF).

The Brain Tumor Center hosts research forum for grad students

The Brain Tumor Center hosts research forum for grad students

Young brain cancer researchers gathered to discuss challenges, share solutions, and explore new ideas.

Stegh inducted as AIMBE fellow

Stegh inducted as AIMBE fellow

Alexander H. Stegh, PhD, professor of neurosurgery, vice chair of research in the Department of Neurosurgery and research director of the Brain Tumor Center, was recently inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.

Chheda Receives Dr. Ralph & Marian Falk Medical Research Trust – Catalyst Award

Chheda Receives Dr. Ralph & Marian Falk Medical Research Trust – Catalyst Award

Milan G. Chheda, MD, Associate Professor, Division of Oncology, received the Dr. Ralph & Marian Falk Medical Research Trust – Catalyst Award, to fund his project titled: Genetic arming of Zika virus to treat patients with glioblastoma.

Brain tumors:Fighting with targeted tools

Brain tumors:Fighting with targeted tools

Whether malignant or benign, a brain tumor is life-altering. Malignant tumors can spread and become deadly.

Device for noninvasive brain biopsies via blood draw moves closer to market approval

Device for noninvasive brain biopsies via blood draw moves closer to market approval

FDA grants WashU-based technology ‘Breakthrough Device’ designation

Predicting survival in glioblastoma with multimodal neuroimaging and machine learning

The ability to predict survival before treatment in GBM patients would lead to improved disease management, clinical trial enrollment, and patient care.

Noninvasive, ultrasound-based brain biopsy is feasible, safe in people

Noninvasive, ultrasound-based brain biopsy is feasible, safe in people

Sonobiopsies generate genetic, molecular data to inform treatment decisions for brain diseases

WashU Neurosurgery welcomes back Dr. Bhuvic Patel

WashU Neurosurgery welcomes back Dr. Bhuvic Patel

Brain tumor neurosurgeon is returning to his WashU roots.

A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma

The primary objective of this pilot phase Ib study was to validate the on-target effect of tadalafil on inhibiting MDSCs in peripheral blood and its safety when combined with chemoradiotherapy in GBM patients.

Two new researchers join Brain Tumor Center

Two new researchers join Brain Tumor Center

Rui Tang, PhD and Yang (Eric) Li, PhD, have joined the Brain Tumor Center as assistant research professors.

Brain Tumor Center welcomes new surgeon

Brain Tumor Center welcomes new surgeon

Dimitrios Mathios, MD, a brain tumor neurosurgeon from the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, has been named to the WashU Neurosurgery faculty as an assistant professor.

Patients with brain cancer may benefit from treatment to boost white blood cells

Patients with brain cancer may benefit from treatment to boost white blood cells

Blocking immune suppressor cells in mice with glioblastoma improved survival

St. Louis Blues Fight Cancer (Part 1)

St. Louis Blues Fight Cancer (Part 1)

Brain Tumor Center Director Dr. Albert Kim is interviewed about the advantage of care at Siteman Cancer Center.

Brain Tumor Center is Hiring

Brain Tumor Center is Hiring

Does your research focus on fundamental brain tumor biology, immunology or genetics? Or on translational sciences to develop next generation (nano)therapies and device technologies? We want to hear from you. Consider applying for tenure track faculty positions in the WashU BTC.

Simple blood test predicts neurotoxic complications of CAR-T cell therapy

Simple blood test predicts neurotoxic complications of CAR-T cell therapy

Identifying high-risk patients could improve cancer care.

Kim named inaugural Danforth WashU Physician Scientist Scholar

Kim named inaugural Danforth WashU Physician Scientist Scholar

Neurosurgeon Albert H. Kim is nationally recognized expert on brain tumors.

Stegh named Brain Tumor Center research director

Stegh named Brain Tumor Center research director

Alexander H. Stegh, PhD, a leading brain cancer scientist, has been named research director of the Brain Tumor Center at Siteman Cancer Center

New Brain Tumor Center at Siteman Cancer Center

New Brain Tumor Center at Siteman Cancer Center

The Center’s multidisciplinary approach has already led to several ground-breaking clinical trials, offered at Siteman Cancer Center, including immunotherapy, genomics-based precision medicine, and laser technology to kill tumors from the inside out.

Brain Tumor Center established at Siteman Cancer Center

Brain Tumor Center established at Siteman Cancer Center

Neurosurgeon and scientist Albert H. Kim appointed director